Protocol for Liberation from Mechanical Ventilation
Daily Readiness Assessment
Implement a standardized daily screening protocol performed by respiratory therapists or nurses to identify patients ready for weaning, with physician approval required only for the final extubation decision. 1
Assess all of the following criteria each morning:
- Resolution or significant improvement of the primary condition requiring mechanical ventilation 1
- Adequate oxygenation: PaO₂ >55 mmHg on FiO₂ ≤0.40, with PaO₂/FiO₂ ≥200 1
- Low ventilatory requirements: PEEP ≤5 cm H₂O, pressure support ≤8 cm H₂O 1
- Hemodynamic stability: No active myocardial ischemia, no vasopressor requirements, mean arterial pressure >65 mmHg 1, 2
- Adequate mental status: Patient arousable with light or no sedation 1
- Respiratory mechanics: RSBI ≤105 breaths/min/L (ideally <80) measured after 30-60 minutes of spontaneous breathing 1
- Airway protection: Intact cough on suctioning with minimal secretions or effective clearance mechanism 1
Spontaneous Breathing Trial (SBT) Protocol
Standard-Risk Patients
Conduct the initial SBT using pressure support ventilation of 5-8 cm H₂O with PEEP 5 cm H₂O rather than T-piece, as this approach increases SBT success rates from 76.7% to 84.6% and extubation success from 68.9% to 75.4%. 3, 1
SBT settings:
High-Risk Patients
For patients at high risk of extubation failure, conduct a longer SBT of 60-120 minutes and consider using T-piece or CPAP without pressure support for more accurate assessment of true extubation readiness. 1, 4
High-risk criteria include:
- Age >65 years 3
- Cardiac failure as cause of respiratory failure 3
- APACHE II score >12 on day of extubation 3
- Failed more than one SBT 3
- PaCO₂ >45 mmHg after extubation 3
- More than one comorbid condition (COPD, CHF) 3
- Weak cough or excessive secretions 3
- Prolonged mechanical ventilation (>14 days) 4
SBT Failure Criteria - Stop Immediately If:
- Respiratory rate >35 breaths/min or increasing trend 1
- SpO₂ <90% 1
- Heart rate >140 bpm or sustained increase >20% 1
- Systolic blood pressure >180 mmHg or <90 mmHg 1
- Increased anxiety or diaphoresis 1
- Use of accessory muscles or abdominal paradox 1
If the SBT fails, return the patient to full ventilatory support for at least 24 hours before attempting another trial; do not repeat SBTs on the same day as this can cause respiratory muscle fatigue and worsen outcomes. 4
Post-Extubation Management
Standard-Risk Patients
Extubate directly to supplemental oxygen via face mask or nasal cannula, targeting SpO₂ 88-92%. 1
- Monitor SpO₂, respiratory rate, and work of breathing continuously for the first 24 hours 1
- Use supplemental oxygen cautiously, particularly in patients with chronic hypercapnia, to avoid masking hypoventilation or atelectasis 1
High-Risk Patients - Prophylactic NIV or HFNC
For high-risk patients who pass the SBT, apply prophylactic noninvasive ventilation (NIV) immediately after extubation (within 1 hour) rather than waiting for respiratory failure, as this reduces reintubation rates (RR 1.14,95% CI 1.05-1.23), ICU mortality (RR 0.37,95% CI 0.19-0.70), and ICU length of stay by 2.48 days. 3
NIV settings:
Alternative: High-flow nasal cannula (HFNC) reduces reintubation rates compared to conventional oxygen therapy (4% vs 21%, P=0.01) and may be used in low-risk patients or when NIV is not tolerated 3
Patients with hypercapnia (PaCO₂ >45 mmHg) during the SBT derive particular benefit from prophylactic NIV, with reduced 90-day mortality (RR 0.58,95% CI 0.27-1.22). 3
Definition of Extubation Success
Extubation is considered successful if the patient does not require reintubation or noninvasive ventilation within 48 hours. 4
- The acceptable extubation failure rate should be 5-10%; higher rates suggest inadequate assessment 4
- Approximately 10% of patients who pass an SBT will still fail extubation within 48 hours 1, 4
Management of Difficult or Prolonged Weaning
Classification
- Simple weaning: Successfully pass first SBT and extubate on first attempt (70% of patients) 1
- Difficult weaning: Require up to 3 SBTs or up to 7 days from first SBT (15% of patients) 1
- Prolonged weaning: Require >3 SBTs or >7 days after first SBT (15% of patients) 1
Approach to Difficult/Prolonged Weaning
For patients who fail multiple SBTs, switch from T-piece trials to gradual reduction of pressure support ventilation (reduce by 2 cm H₂O every 24-48 hours) rather than repeating daily T-piece trials, as this reduces inspiratory muscle effort and cardiovascular stress. 2
Identify and address reversible causes:
- Respiratory muscle weakness: Perform diaphragmatic ultrasound to evaluate diaphragm thickness and excursion 2
- Fluid overload: Consider forced diuresis if pulmonary edema is evident; fluid overload can exceed 20 liters in difficult-to-wean patients 2
- Metabolic alkalosis: Bicarbonate >30 mmol/L diminishes respiratory drive; correct by reducing diuretics and repleting chloride with normal saline 2
- Inadequate oxygenation: Increase PEEP to 8-10 cm H₂O while targeting PaO₂/FiO₂ >200 mmHg; keep driving pressure <15 cm H₂O 2
- Excessive sedation: Reduce sedation to encourage spontaneous breathing efforts 2
For patients with hypercapnic respiratory failure (especially COPD), consider early transition to NIV to facilitate weaning, which reduces mortality (RR 0.54,95% CI 0.41-0.70), weaning failure (RR 0.61,95% CI 0.48-0.79), and ventilator-associated pneumonia (RR 0.22,95% CI 0.15-0.32). 1
Critical Pitfalls to Avoid
- Do not commence weaning when PaO₂ <55 mmHg on FiO₂ ≥0.40, as weaning failure probability is markedly increased 1
- Do not use SIMV for weaning, as it is inferior to pressure support and T-piece methods 1
- Do not rely solely on SBT success to predict extubation readiness; also assess upper airway patency, bulbar function, sputum load, and cough effectiveness 1, 4
- Do not delay extubation in patients who pass their first SBT, are <65 years old, have normal PaCO₂, and have no significant respiratory or cardiac comorbidities, as these low-risk patients rarely require prophylactic NIV 3
- Avoid premature weaning in patients still requiring vasopressors or with unresolved primary pathology 1